Previous 10 | Next 10 |
IRVINE, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its first quarter 2023...
2023-03-16 15:29:17 ET Shares of Inari Medical (NASDAQ: NARI) were up 16.9% for the week as of late Thursday afternoon, according to data provided by S&P Global Market Intelligence . The medical device stock closed last week at $56.59, then rose to as high as $66.49 on Thurs...
2023-03-06 09:11:07 ET Inari Medical ( NASDAQ: NARI ) added ~5% pre-market Monday after a study indicated that the company’s FDA-cleared FlowTriever device cut the mortality risk by 90% in patients with high-risk pulmonary embolism. The FLAME study was a prospec...
IRVINE, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced positive results from the FLAME study in high-risk...
Summary Inari Medical has solid top-line growth with expansion in core and new product lines. It continues to focus on reinvestment into future growth, especially in international markets. Operating losses are widening as a result of this. Net-net, I reiterate my buy rating. ...
Inari Medical, Inc. (NARI) Q4 2022 Earnings Conference Call February 27, 2023, 04:30 PM ET Company Participants Caroline Corner - IR Drew Hykes - President and CEO Mitch Hill - CFO Tom Tu - Chief Medical Officer Conference Call Participants Travis Steed...
Inari Medical press release ( NASDAQ: NARI ): Q4 GAAP EPS of -$0.11 beats by $0.06 . Revenue of $107.8M (+29.5% Y/Y) beats by $2.95M . For the full year 2023, we are reaffirming our revenue guidance range of $470 million to $480 million, vs. consensus of $471.63M....
IRVINE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its fourth quarter and ...
Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended December 31, 2022, Baron Health Care Fund rose 9.08% (Institutional Shares) vs. the 11.54% gai...
Inari Medical ( NASDAQ: NARI ) is scheduled to announce Q4 earnings results on Monday, February 27th, after market close. The consensus EPS Estimate is -$0.17 and the consensus Revenue Estimate is $104.85M (+26.0% Y/Y). Over the last 3 months, EPS estimates have seen 2 upwar...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
SAN FRANCISCO, June 27, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...